Selenite supplementation in euthyroid subjects with thyroid
 peroxidase antibodies

Eskes, Sylvia; Endert, Erik; Birnie, Erwin; Hollenbach, B.; Schomburg, Lutz; Köhrle, Josef; Wiersinga, Wilmar

doi:10.1111/cen.12284

S. Eskes (Sylvia), E. Endert (Erik), E. Birnie (Erwin), Birgit Hollenbach (B.), L. Schomburg (Lutz), J. Köhrle (Josef) and W.M. Wiersinga (Wilmar)

2013-07-31

Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies

Clinical Endocrinology Issue first published online: 31 JUL 2013 p. 1- 8

Abstract

Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyroid patients upon selenium supplementation.

Additional Metadata
Keywords	endocrinology, Euthyroid thyroid peroxidase, autoimmunity
Persistent URL	doi.org/10.1111/cen.12284, hdl.handle.net/1765/50381
Journal	Clinical Endocrinology
Organisation	Erasmus School of Health Policy & Management (ESHPM)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Eskes, S., Endert, E., Birnie, E., Hollenbach, B., Schomburg, L., Köhrle, J., & Wiersinga, W. (2013). Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clinical Endocrinology, (first published online: 31 JUL 2013), 1–8. doi:10.1111/cen.12284

Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies

Publication

Publication

About

Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies

Publication

Publication

Workflow

Workflow

Add Content